LU87041A1 - Esters retinoiques de macrolides,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant - Google Patents

Esters retinoiques de macrolides,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant Download PDF

Info

Publication number
LU87041A1
LU87041A1 LU87041A LU87041A LU87041A1 LU 87041 A1 LU87041 A1 LU 87041A1 LU 87041 A LU87041 A LU 87041A LU 87041 A LU87041 A LU 87041A LU 87041 A1 LU87041 A1 LU 87041A1
Authority
LU
Luxembourg
Prior art keywords
retinoyl
esters
trans
garlic
josamycin
Prior art date
Application number
LU87041A
Other languages
English (en)
French (fr)
Inventor
Michel Philippe
Henri Sebag
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Priority to LU87041A priority Critical patent/LU87041A1/fr
Priority to US07/235,853 priority patent/US5045533A/en
Priority to JP63276360A priority patent/JP2736258B2/ja
Priority to CA000582109A priority patent/CA1313662C/fr
Priority to ES198888402771T priority patent/ES2009730T3/es
Priority to DE198888402771T priority patent/DE315540T1/de
Priority to AT88402771T priority patent/ATE75482T1/de
Priority to DE8888402771T priority patent/DE3870582D1/de
Priority to EP88402771A priority patent/EP0315540B1/fr
Publication of LU87041A1 publication Critical patent/LU87041A1/fr
Priority to GR89300130T priority patent/GR890300130T1/el
Priority to GR920401501T priority patent/GR3005156T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • C07H15/16—Lincomycin; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Cosmetics (AREA)
  • Pyrane Compounds (AREA)
LU87041A 1986-05-06 1987-11-04 Esters retinoiques de macrolides,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant LU87041A1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
LU87041A LU87041A1 (fr) 1987-11-04 1987-11-04 Esters retinoiques de macrolides,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
US07/235,853 US5045533A (en) 1986-05-06 1988-08-24 Retinoic esters of antibiotics and pharmaceutical and cosmetic compositions containing them
JP63276360A JP2736258B2 (ja) 1987-11-04 1988-11-02 マクロライドのレチノイン酸エステル、その製造方法及びこれを含有する化粧料組成物
DE198888402771T DE315540T1 (de) 1987-11-04 1988-11-03 Retinoesaeure-ester von makroliden, ihre verfahren zur herstellung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
ES198888402771T ES2009730T3 (es) 1987-11-04 1988-11-03 Esteres retinoicos de macrolidos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
CA000582109A CA1313662C (fr) 1987-11-04 1988-11-03 Esters retinoiques de macrolides, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
AT88402771T ATE75482T1 (de) 1987-11-04 1988-11-03 Retinoesaeure-ester von makroliden, ihre verfahren zur herstellung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
DE8888402771T DE3870582D1 (de) 1987-11-04 1988-11-03 Retinoesaeure-ester von makroliden, ihre verfahren zur herstellung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
EP88402771A EP0315540B1 (fr) 1987-11-04 1988-11-03 Esters rétinoiques de macrolides, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
GR89300130T GR890300130T1 (en) 1987-11-04 1990-01-30 Retinoic esters of macrolides, method for their preparation and pharmaceutical and cosmetic compositions containing them
GR920401501T GR3005156T3 (el) 1987-11-04 1992-07-13

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU87041 1987-11-04
LU87041A LU87041A1 (fr) 1987-11-04 1987-11-04 Esters retinoiques de macrolides,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant

Publications (1)

Publication Number Publication Date
LU87041A1 true LU87041A1 (fr) 1989-06-14

Family

ID=19730984

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87041A LU87041A1 (fr) 1986-05-06 1987-11-04 Esters retinoiques de macrolides,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant

Country Status (9)

Country Link
US (1) US5045533A (el)
EP (1) EP0315540B1 (el)
JP (1) JP2736258B2 (el)
AT (1) ATE75482T1 (el)
CA (1) CA1313662C (el)
DE (2) DE315540T1 (el)
ES (1) ES2009730T3 (el)
GR (2) GR890300130T1 (el)
LU (1) LU87041A1 (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2282596B (en) * 1993-10-06 1998-04-15 Ciba Geigy Ag Water-soluble retinoids
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
AU2004258944B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004264939A1 (en) 2003-08-11 2005-02-24 Middlebrook Pharmaceuticals, Inc. Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1771158A4 (en) 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp TABLET FOR PULSED DELIVERY
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US11072575B1 (en) * 2020-09-19 2021-07-27 Xi'an Taikomed Pharmaceutical Technology Co., Ltd. Method of preparing a cinnamyl alcohol retinoic acid ester with antioxidant and antibacterial activities
WO2023187197A1 (en) * 2022-03-31 2023-10-05 Université De Genève Conjugates of antimicrobial agents with a tocopheryl or tocotrienyl group

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056616A (en) * 1976-03-05 1977-11-01 Schering Corporation Rosamicin derivatives and method of using same
JPS60126296A (ja) * 1983-12-13 1985-07-05 Kyowa Hakko Kogyo Co Ltd ３，３”，４”−トリ−ｏ−アシルスピラマイシン１
FR2582000B1 (fr) * 1985-05-14 1987-06-26 Oreal Esters gras bi ou tri-eniques d'erythromycine a, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
FR2598420B1 (fr) * 1986-05-06 1991-06-07 Oreal Nouveaux esters retinoiques d'antibiotiques, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant

Also Published As

Publication number Publication date
EP0315540B1 (fr) 1992-04-29
EP0315540A1 (fr) 1989-05-10
ES2009730A4 (es) 1989-10-16
CA1313662C (fr) 1993-02-16
JPH01193293A (ja) 1989-08-03
DE315540T1 (de) 1989-10-05
GR890300130T1 (en) 1990-01-31
JP2736258B2 (ja) 1998-04-02
US5045533A (en) 1991-09-03
GR3005156T3 (el) 1993-05-24
ES2009730T3 (es) 1993-08-01
ATE75482T1 (de) 1992-05-15
DE3870582D1 (de) 1992-06-04

Similar Documents

Publication Publication Date Title
LU87041A1 (fr) Esters retinoiques de macrolides,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
EP0315539B1 (fr) Esters aromatiques polycycliques d'antibiotiques macrolidiques et lincosamidiques, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
LU85558A1 (fr) Nouveaux derives naphtaleniques a action retinoique,leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
CA1253492A (fr) Esters gras bi ou tri-eniques d'erythromycine a, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
BE1001203A3 (fr) Composition a base de derives d'hydroxypyridone pour diminuer la chute des cheveux.
EP0409728A2 (fr) Esters bi-aromatiques, leur procédé de préparation et leur utilisation en médecine humaine ou vétérinaire et en cosmétique
LU86945A1 (fr) Compositions pharmaceutiques et cosmetiques a base de pyridones et d'agents antibacteriens
EP0315536B1 (fr) Esters polyaromatiques d'antibiotiques macrolidiques et lincosamidiques, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
CH656132A5 (fr) Derives de n-carbamoyl d'isothiazolo-(5,4b) pyridine one-3 leur procede de preparation, et compositions cosmetiques les contenant.
CA1313657C (fr) Esters bioaromatiques d'antibiotiques macrolidiques et lincosamidiques, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
EP0315535B1 (fr) Esters cycloaliphatiques insaturés d'antibiotiques macrolidiques et lincosamidiques, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
EP0404640A1 (fr) Nouveaux dérivés de tétrahydro-5,6,7,8 naphtalénol-1, leur procédé de préparation et leur utilisation en tant qu'agents antioxydants dans des compositions cosmétiques et pharmaceutiques les contenant
CA1313658C (fr) Esters aromatiques d'antibiotiques macrolidiques et lincosamdiques, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
EP0388314B1 (fr) Esters rétinoiques de l-cladinose, leur procédé de préparation et leur utilisation en médecine humaine ou vétérinaire et en cosmétique
EP0315534B1 (fr) Esters du type étrétinique ou apparenté d'antibiotiques macrolidiques et lincosamidiques, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
CA1273580A (fr) Compositions pharmaceutiques contenant a titre de principe actif au moins un mono, di ou tri-ester de dihydroxy-1,8 phenyl-10 anthrone-9 ou anthranol-9
FR2580631A1 (fr) Hydroxy-1 acyloxy-8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
CH651290A5 (fr) Derives de la serie des dihydroxy-1,8 anthrones-9 substituees en position 10 par un radical insature.
CA2004757A1 (fr) Ethers et/ou esters lipophiles de d-desosamine, leur procede de preparation et leur utilisation en tant qu'agents anti-bacteriens et antifongiques